Disease control should be the goal of therapy for WM patients

Efstathios Kastritis; Meletios A Dimopoulos

doi:10.1182/bloodadvances.2017005645

Related publications

Article2019

PS1378 AN EARLY, WITHIN THE FIRST MONTH, AND DEEP RESPONSE, SHOULD BE THE GOAL OF THERAPY IN AL AMYLOIDOSIS

Efstathios Kastritis, Eleni A. Karatrasoglou, Ioanna Dialoupi, Maria Gavriatopoulou, Μαρία Ρούσσου, Despina Fotiou, Nikolaos Kanellias, Ioannis Ntanasis‐Stathopoulos, E. Eleutherakis‐Papaiakovou, Efstathios Manios, Magdalini Migkou, Αριστέα-Μαρία Παπανώτα, Evangelia Papadopoulou, K. Stamatelopoulos, Argyrios Ntalianis, Asimina Papanikolaou, Erasmia Psimenou, Charikleia Gakiopoulou, Ourania Tsitsilonis, M.E. Tselegkidi, Ioannis P. Trougakos, Ioannis V. Kostopoulos, Evangelos Terpos, Meletios A Dimopoulos

Letter2007

Disease control should be the goal of therapy for WM patients

Abstract

Discussion(0)

Related publications

PS1378 AN EARLY, WITHIN THE FIRST MONTH, AND DEEP RESPONSE, SHOULD BE THE GOAL OF THERAPY IN AL AMYLOIDOSIS

Polytetrafluoroethylene‐covered stent deployment in the setting of Kawasaki disease

Skin lesions in a patient with Cobalamin C disease in poor metabolic control

A Microporous Metal–Organic Framework for Gas‐Chromatographic Separation of Alkanes

Why Voxel-Based Morphometry Should Be Used